Max Robotics — Global Service Robot Directory + US Certification

About

Amandine Maulard is a leading gynecologic oncologist whose research has fundamentally reshaped the surgical management of cervical cancer, particularly for young women seeking to preserve fertility. Her landmark 2016 systematic review on oncological outcomes after fertility-sparing surgery, cited over 270 times, provided critical evidence that conservative surgical approaches could be safe and effective, establishing a new standard for patient counseling and treatment selection. Dr. Maulard’s most impactful contribution is her central role in the international SHAPE trial (CCTG CX.5), a groundbreaking phase III randomized study comparing radical hysterectomy with simple hysterectomy for low-risk early-stage cervical cancer. This practice-changing trial demonstrated that less radical surgery offers equivalent oncological safety with significantly reduced morbidity, challenging decades-old surgical dogma. With over 300 total citations for these two works alone, her research has directly improved quality of life for countless patients while maintaining excellent cancer outcomes. Dr. Maulard’s work exemplifies how rigorous clinical investigation can transform surgical paradigms, making her a pivotal figure in modern gynecologic oncology.